Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Amortization (2021 - 2023)

Historic Amortization for ADC Therapeutics (ADCT) over the last 3 years, with Q3 2023 value amounting to $2.0 billion.

  • ADC Therapeutics' Amortization rose 4.95% to $2.0 billion in Q3 2023 from the same period last year, while for Sep 2023 it was $2.0 billion, marking a year-over-year increase of 4.95%. This contributed to the annual value of $2.0 billion for FY2022, which is 4.95% up from last year.
  • As of Q3 2023, ADC Therapeutics' Amortization stood at $2.0 billion, which was up 4.95% from $2.0 billion recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Amortization peaked at $2.0 billion during Q1 2023, and registered a low of $2.0 billion during Q4 2021.
  • Moreover, its 3-year median value for Amortization was $2.0 billion (2022), whereas its average is $2.0 billion.
  • As far as peak fluctuations go, ADC Therapeutics' Amortization increased by 4.95% in 2022, and later grew by 4.95% in 2023.
  • Over the past 3 years, ADC Therapeutics' Amortization (Quarter) stood at $2.0 billion in 2021, then increased by 0.05% to $2.0 billion in 2022, then increased by 0.05% to $2.0 billion in 2023.
  • Its last three reported values are $2.0 billion in Q3 2023, $2.0 billion for Q2 2023, and $2.0 billion during Q1 2023.